Attitudes and distress levels in women at risk to carry aBRCA1/BRCA2 gene mutation who decline genetic testing-Reference-Cited by-同舟云学术

Attitudes and distress levels in women at risk to carry aBRCA1/BRCA2 gene mutation who decline genetic testing

Published:2003-05-29 Issue:3 Volume:119A Page:266-272
ISSN:0148-7299
Container-title:American Journal of Medical Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Lodder Litanja,Frets Petra G.,Trijsburg R. Willem,Klijn Jan G.M.,Seynaeve Caroline,Tilanus Madeleine M.A.,Bartels Carina C.M.,Meijers-Heijboer E Johanna,Verhoog Leon C.,Niermeijer Martinus F.

Publisher

Wiley

Subject

Genetics (clinical)

Reference18 articles.

1. BRCA1 and BRCA2: from molecular genetics to clinical medicine.

2. Personality Traits of Women with Breast Cancer: Before and after Diagnosis

3. Non-Participation in Predictive Testing for Huntington's Disease: Individual Decision-Making, Personality and Avoidant Behaviour in the Family

4. Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: The Yugoslav prospective study

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes;The Annals of The Royal College of Surgeons of England;2024-01

2. Germline Testing and Somatic Tumor Testing for BRCA1/2 Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?;JCO Precision Oncology;2022-10

3. Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect;Breast Cancer Research and Treatment;2018-05-28

4. Time to End the Use of Genetic Test Results in Life Insurance Underwriting;Journal of Law, Medicine & Ethics;2018

5. Satisfaction with Decision Regarding BRCA1/2 Genetic Testing and Willingness to Undergo BRCA1/2 Genetic Testing in the Future Among Breast Cancer Patients who Had not Previously Undergone BRCA1/2 Genetic Testing in Japan;The Showa University Journal of Medical Sciences;2018